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Pediatric patients are among the recipients of most antibiotic treatment in hospitals so as to induce 
irrational use of antibiotics. This study aims to monitor the use of antibiotics in pediatric using ATC/DDD 
methods and DU 90%. This study is a descriptive study with a retrospective study by taking data from 
medical records to assess the use of antibiotics in pediatric patients with various diseases in the hospital. 
Quantitative data analysis using ATC/DDD methods showed that the widely used antibiotic was 
ceftriaxone 16,93% DDD. Antibiotics that include into the DU segment 90% use in the order of the 
largest to the smallest, respectively are ceftriaxone, metronidazole, cefotaxime, gentamycin, polymyxin 
B, colistin, cotrimoxazole, cefuroxime, and meropenem. The prescribing effect of short-term antibiotic 
use in basic medical services may increase the incidence of resistance. 
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Antibiotics are chemical compounds 
produced by microorganisms specifically 
produced by fungi or produced synthetically that 
can kill or inhibit the development of bacteria and 
other organisms. Antibiotics are the drugs most 
widely used in infections caused by bacteria. 
Various studies have found that about 40-62% of 
antibiotics are used inappropriately, among other 
diseases that actually do not require antibiotics. 
Based on its mechanism against bacteria 
(beta-lactam groups such as penicillin, 
cephalosporin, carbapenem, monobactam, and 
other antibiotics such as vancomycin, bacitracin, 
phosphomycin, and daptomycin), inhibitors of 
bacterial protein synthesis (aminoglycosides, 
macrolides, tetracycline). Inhibiting the synthesis 
of folate (sulfonamides and trimethoprim), 
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changing cell membrane permeability 
(polymiksin, amphotericin B, gramicidin, nystatin, 
colistin), interfering with, DNA synthesis 
(metronidazole, quinolone, novobiocin) and 
interfering with RNA synthesis (Rifampicin). 
In research, the relatively high-intensity 
quality raises various problems and is a global 
threat to health, especially bacterial resistance to 
antibiotics. Besides having an impact on morbidity 
and mortality, it also has a very high negative 
economic and social impact. Initially, the 
resistance occurred at the hospital level, but 
gradually it also developed in the community, 
especially Streptococcus pneumonia, 
Staphylococcus aureus, and Escherichia coli.   
The use of antibiotics needs to be monitored 
because it can increase the occurrence of 
resistance. Antibiotic resistance has become a 
concern of people in all parts of the world, and it 
requires a joint awareness of the relationship 
between the level of antibiotic resistance with 
antibiotic use patterns. Information about 
antibiotic use patterns can be used as an early 
detection tool for irrationality and as a source of 
information in controlling antibiotic resistance. A 
study on antibiotic use is needed to improve the 
rationality of antibiotic use. WHO has determined 
that ATC / DDD and DU 90% are standardized 
methods for drug use studies, and the advantage of 
using these studies is that they can be briefly 
exposed. 
This study aims to evaluate the use of 
antibiotics in pediatric patients aged 1 - 5 years in 
one of the government hospitals in East 
Kalimantan using the ATC / DDD and DU 90% 
analysis methods. This research is expected to 
increase awareness of the use of antibiotics for 
health workers and local government in an effort 
to increase rationality in the use of antibiotics in 
children in the community. 
 
■ Experimental 
The study was conducted at a regional 
hospital in East Borneo using the retrospective 
method. Data obtained from medical records of 
pediatric patients aged 1-5 years who are 
hospitalized. Data were analyzed descriptively and 
processed using ATC / DDD and DU 90% 
methods for quantity assessment. 
■ Results and Discussion 
This research was conducted at a government 
hospital in East Borneo by collecting medical 
record data on pediatric patients aged 1-5 years. 
The sample used was patients who used more than 
one antibiotic. The use of antibiotics requires 
special attention to avoid problems related to the 
use of antibiotics in further treatment. The results 
showed the value of gender distribution in 




Table.1. Gender Distribution in Pediatric Patients  
Gender Number of patients (%)  
Male  56 
Female  44 




Based on data from Table 1 above result the 
number of male patients is more than the number 
of female patients are males by 56% (35 votes), 
and female patients by 44% (27 people) this is 
because boys have higher activity for the playing 
out of the house, so it is more susceptible to 
disease infection. 
The results for the analysis of the types and 




Table.2. Distribution of Antibiotic Types and Doses  
Types of Antibiotics Number of patients (%)  
Cefotaxime    23,71 
Ceftriaxone    14,44 
Gentamicin   12,37 
Meropenem   8,25 
Cortimoksazole  8,25 
Ampicillin   8,25 
Metronidazole   6,19 
Erythromycin   5,15 
Spiramycin   3,09 
Cefixime   3,09 
Amikacin   2,06 
Kloramfenikol   1,03 
Amoxicillin   1,03 
Cefuoroxime   1,03 
Polymixin B  1,03 
colistin  1,03 
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Table.3. Consumption Patterns of Antibiotic Types  
Code ATC AntibiotiCS ∑ Dose (g) DDD % Segmen DU 
J01DD04 Ceftriaxone  10,95 5,47 16,93  
G01AF01 Metronidazole  2,46 4,92 15,23  
J01DD01 Cefotaxime  19,10 4,77 14,77  
J01GB03 Gentamycin  0,69 2,87 8,88  
J01XB02 Polymyxine B 0,38 2,54 7,83  
J01XB01 Colistin  7,35 MU 2,45 7,54  
J01EE01 Cotrimoxazole 4,57 2,28 7,05  
J01DC02 Cefuroxime 1,12 2,24 6,92  
J01DH02 Meropenem 4,00 2,00 6,19 90% 
J01CA01 Ampicilin 2,91 1,45 4,48  
J01BA01 Chlorampenicol 1,50 0,50 1,54  
J01DD08 Cefixime 0,11 0,27 0,83  
J01DB05 Sefadroksil 0,50 0,25 0,77  
J01FA02 Spiramycin 0,35 0,12 0,37  
J01CR02 Amoxicilin 0,24 0,08 0,24  
J01GB06 Amikacin 0,06 0,06 0,18  
J01FA01 Erythromycin 0,04 0,04 0,15 10% 




Based on the table 2, it can be seen that the 
use of cefotaxime antibiotics by 23.71% is the most 
widely used antibiotic in patients aged 1-5 years. 
Cefotaxime is a third-generation cephalosporin 
antibiotic that has broad-spectrum activity against 
gram-positive and negative bacteria. Cefotaxime is 
very stable against beta-lactamase hydrolysis, so 
cefotaxime is used as a first-line option in 
penicillin-resistant bacteria. Then the second 
highest antibiotic use is ceftriaxone, which is 
14.43%, which is a broad-spectrum antibiotic. In 
third place is gentamicin at 12.37%. 
Quantitative assessment of antibiotic use is 
carried out using the DDD (Defined Daily Doses) 
method recommended by WHO. The smaller the 
number of antibiotics used shows that doctors are 
more selective in prescribing antibiotics so that 
they are closer to the principle of rational use of 
antibiotics. The biggest antibiotic use is 
ceftriaxone, which is 16.93% DDD, followed by 
metronidazole 15.23% DDD. If seen in Table 2, it 
was mentioned that the number of patients using 
the antibiotic cefotaxime more usage when 
compared with ceftriaxone. This is because the 
WHO DDD standard value of cefotaxime (4g) is 
higher than ceftriaxone (2g) even though 
cefotaxime has a larger dose. Ceftriaxone is an 
antibiotic that has broad-spectrum activity, so it is 
often prescribed by doctors. Based on the antibiotic 
consumption patterns shown in table 3, it is known 
that antibiotics that enter the DU 90% segment use 
the largest to smallest antibiotic groups, namely 
ceftriaxone, metronidazole, cefotaxime, 
gentamycin, polymyxin B, colistin, cotrimoxazole, 
cefuroxime, and meropenem. The DU 90% 
segment serves as an indicator of the quality of 
prescription drugs. This study aims to determine 
drug ranking based on the determined daily dose 
volume (DDD) and determine how many drugs 
enter the 90% DU segment. The study needs to be 
done about the rationality of the use of 
antibiotics, especially antibiotics that enter the 




The results showed that the quantitative use 
of antibiotics ceftriaxone biggest of 16.93% DDD 
and antibiotics are included in the segment DU 
90% that ceftriaxone, metronidazole, cefotaxime, 
gentamycin, polymixin B, colistin, 
cotrimoxazole, cefuroxime, and meropenem.  
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